KTurkington
TL3 Regular · Palermo, IT
Wiki editor. Small, frequent, well-annotated edits.
Joined 19 February 2025 · last posted 3d · groups: wiki-editors
120 posts, newest first. Showing up to 150.
-
How shortages have affected compounding permissions Replied, post #69 · Access › Shortages · 25 Jul 2026 · 0 likes Worth separating two things that post #65 runs together. Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #29 · Access › Shortages · 21 Jul 2026 · 0 likes This follows post #26 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Evidence quality in the secretagogue literature: an honest assessment Replied, post #3 · Compounds › Secretagogues & GH axis · 19 Jul 2026 · 0 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
Priming a pen and whether the primed volume is wasted Replied, post #12 · Devices › Pens & autoinjectors · 19 Jul 2026 · 20 likes Worth separating two things that post #8 runs together. Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track using the…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #51 · Start Here › Welcome · 17 Jul 2026 · 28 likes post #50 is right about the mechanism and I think understates the practical bit. The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is…
-
Here for the analytics and not much else Replied, post #40 · Lounge › Introductions · 16 Jul 2026 · 0 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
-
[2026 update] Documenting an adverse event properly Replied, post #4 · Safety › Adverse events · 8 Jul 2026 · 6 likes This follows post #3 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #68 · Start Here › Welcome · 8 Jul 2026 · 11 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Immortal time bias in a claims-database study — one year on Replied, post #12 · Evidence › Study critique · 8 Jul 2026 · 26 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #56 · Analytics › Home & field testing · 5 Jul 2026 · 23 likes On post #52 — agreed on the reasoning, with one qualification. Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #2 · Analytics › HPLC & UHPLC · 29 Jun 2026 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #21 · Compounds › Retatrutide · 27 Jun 2026 · 13 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #23 · Analytics › Home & field testing · 23 Jun 2026 · 25 likes I read post #21 twice before replying, because I had assumed the opposite. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #21 · Pharmacology › Receptor biology · 18 Jun 2026 · 0 likes I read post #19 twice before replying, because I had assumed the opposite. Species differences: rodent studies show the same compounds produce effects in rodents that…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #59 · Access › Insurance & coverage · 6 Jun 2026 · 14 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #29 · Clinical › Special populations · 29 May 2026 · 31 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
Follow-up: Sleep quality changes during weight loss Replied, post #32 · Wellbeing › Sleep · 28 May 2026 · 2 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #69 · Practice › Administration · 28 May 2026 · 3 likes Coming back to post #67, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #34 · Safety › Contraindications · 10 May 2026 · 2 likes Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the…
-
Delayed gastric emptying and oral medication absorption: which drugs matter — one year on Replied, post #2 · Practice › Interactions · 1 May 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
[2026 update] What a good consultation looks like from the other side Replied, post #28 · Clinical › Prescriber conversations · 26 Apr 2026 · 5 likes post #27 is right about the mechanism and I think understates the practical bit. What to bring: copies of relevant lab results, pharmacy records (to confirm doses…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #84 · Compounds › Tirzepatide · 15 Apr 2026 · 9 likes post #83 is right about the mechanism and I think understates the practical bit. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #38 · Sourcing › Logistics · 10 Apr 2026 · 0 likes Worth separating two things that post #34 runs together. Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide…
-
Request declined, with reasoning — what changed since Replied, post #28 · Meta › Feature requests · 9 Apr 2026 · 0 likes Feature scope: some requests are for the site itself (search, filtering, navigation). Some are for the documentation (new topics, different formats). Scope helps…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #2 · Sourcing › Independent verification · 8 Apr 2026 · 0 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Follow-up: State-level differences that actually matter Replied, post #58 · Regional › North America · 7 Apr 2026 · 7 likes On post #54 — agreed on the reasoning, with one qualification. Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is…
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #6 · Practice › Reconstitution · 3 Apr 2026 · 1 like Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Grapefruit: why this class is not the class that cares Replied, post #98 · Practice › Interactions · 30 Mar 2026 · 14 likes Coming back to post #96, because the follow-up matters more than the original answer. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A,…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #17 · Sourcing › Red flags · 15 Mar 2026 · 7 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Blinding yourself: practical methods and their limits Replied, post #10 · Research Methods › N-of-1 designs · 11 Mar 2026 · 32 likes I read post #8 twice before replying, because I had assumed the opposite. When to run an n-of-1: this design works when you want to know whether a treatment works for…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #53 · Research Methods › N-of-1 designs · 11 Mar 2026 · 12 likes I read post #51 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Preprint servers and what screening they do Replied, post #83 · Evidence › Preprints · 10 Mar 2026 · 3 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Second pass at: What to keep a record of at the point of payment Replied, post #16 · Sourcing › Payments · 6 Mar 2026 · 0 likes Bank transfer and finality: once a bank transfer is sent, it is final. The money is gone. There is no recourse with the bank if the supplier disappears. That is why…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #73 · Compounds › Semaglutide · 2 Mar 2026 · 20 likes Picking up post #70: that is the part I would want checked first. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #84 · Outcomes › Progress reports · 19 Feb 2026 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: Absolute versus relative contraindications Replied, post #25 · Safety › Contraindications · 14 Feb 2026 · 12 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #83 · Pharmacology › Pharmacokinetics · 14 Feb 2026 · 1 like Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #96 · Clinical › Special populations · 9 Feb 2026 · 10 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
Designing a personal experiment that could change your mind — one year on Replied, post #7 · Research Methods › N-of-1 designs · 1 Feb 2026 · 14 likes On post #3 — agreed on the reasoning, with one qualification. Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1…
-
Amylin receptor signalling and satiety — what changed since Replied, post #22 · Pharmacology › Receptor biology · 28 Jan 2026 · 15 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
Request: export my own posts — one year on Replied, post #39 · Meta › Feature requests · 27 Jan 2026 · 0 likes Community support: if other people support your request, they can reply with "+1" or "I would use that too". Widely-requested features are prioritised.
-
MHRA statements, read directly Replied, post #73 · Regional › UK & Ireland · 22 Jan 2026 · 0 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
-
Personal import allowances, compared — a second dataset Replied, post #53 · Access › International · 17 Jan 2026 · 21 likes post #52 is right about the mechanism and I think understates the practical bit. Compounding in different countries: some countries allow pharmacy compounding under…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #65 · Practice › Side effects · 10 Jan 2026 · 0 likes Worth separating two things that post #61 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Tracking that stops updating and then resumes — the long version Replied, post #60 · Sourcing › Logistics · 2 Jan 2026 · 11 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
About the Other compounds category Replied, post #5 · Compounds › Other compounds · 19 Dec 2025 · 24 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #10 · Access › International · 13 Dec 2025 · 0 likes On post #6 — agreed on the reasoning, with one qualification. Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is…
-
Coverage in the US: a map of the usual obstacles Replied, post #21 · Regional › North America · 11 Dec 2025 · 5 likes I read post #19 twice before replying, because I had assumed the opposite. United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated.…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #15 · Clinical › Bloodwork · 24 Nov 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #42 · Analytics › Method validation · 24 Nov 2025 · 22 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What a purity-only report leaves out Replied, post #101 · Sourcing › Independent verification · 24 Nov 2025 · 0 likes On post #97 — agreed on the reasoning, with one qualification. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #53 · Practice › Interactions · 19 Nov 2025 · 9 likes Worth separating two things that post #49 runs together. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by…
-
Absolute versus relative contraindications Replied, post #6 · Safety › Contraindications · 19 Nov 2025 · 19 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #6 · Safety › Contraindications · 16 Nov 2025 · 3 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
What a confidence interval means, from scratch — the long version Replied, post #17 · Research Methods › Statistics · 14 Nov 2025 · 10 likes post #16 answers the question as asked. The question underneath it is different. Confounding: a third variable explains an apparent association. In randomised data,…
-
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #10 · Compounds › Oral incretins · 10 Nov 2025 · 0 likes This follows post #7 rather than contradicting it. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #12 · Compounds › Retatrutide · 8 Nov 2025 · 32 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Follow-up: Why appetite effects are mostly central Replied, post #82 · Pharmacology › Receptor biology · 31 Oct 2025 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Amylin receptor signalling and satiety Replied, post #18 · Pharmacology › Receptor biology · 29 Oct 2025 · 3 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #30 · Start Here › How to Ask · 27 Oct 2025 · 29 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #111 · Analytics › HPLC & UHPLC · 17 Oct 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #4 · Practice › Dosing & titration · 14 Oct 2025 · 12 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #19 · Safety › Adverse events · 14 Oct 2025 · 0 likes Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2.…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #22 · Devices › Pens & autoinjectors · 7 Oct 2025 · 7 likes Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen.
-
An orphaned page with no inbound links — the long version Started this topic · Meta › Wiki maintenance · 6 Oct 2025 · 37 likes Posting this under the heading it deserves: An orphaned page with no inbound links — the long version Everything below is what sits behind that. Process question about…
-
Documentation that materially improves an appeal's chances Replied, post #19 · Access › Insurance & coverage · 5 Oct 2025 · 2 likes Picking up post #16: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #122 · Access › Insurance & coverage · 16 Sep 2025 · 24 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #56 · Practice › Reconstitution · 16 Sep 2025 · 19 likes Worth separating two things that post #52 runs together. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe…
-
Lipase elevation without symptoms: the interpretation problem Replied, post #8 · Clinical › Bloodwork · 14 Sep 2025 · 0 likes This follows post #5 rather than contradicting it. A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #114 · Data & Tools › Calculators · 12 Sep 2025 · 0 likes This follows post #111 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #55 · Compounds › Semaglutide · 8 Sep 2025 · 5 likes Worth separating two things that post #51 runs together. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #30 · Compounds › Oral incretins · 2 Sep 2025 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #2 · Compounds › Retatrutide · 31 Aug 2025 · 4 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Request: show the solution author in the topic list Started this topic · Meta › Feature requests · 15 Aug 2025 · 3 likes Posting this under the heading it deserves: Request: show the solution author in the topic list Everything below is what sits behind that. Nominating something for…
-
A request that was declined, and the reasoning — a second dataset Replied, post #85 · Documentation › Wiki requests · 14 Aug 2025 · 28 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
When a preprint is the best available evidence and we say so Replied, post #54 · Evidence › Preprints · 14 Aug 2025 · 0 likes post #53 answers the question as asked. The question underneath it is different. Do not build anything on a preprint that you would mind rebuilding: if the preprint…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #9 · Evidence › Preprints · 13 Aug 2025 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
When a tidy document is a signal and when it is decoration — does this still hold? Replied, post #3 · Analytics › COA interpretation · 9 Aug 2025 · 7 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #60 · Compounds › Repair & healing peptides · 6 Jul 2025 · 0 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #48 · Compounds › Semaglutide · 30 Jun 2025 · 0 likes post #47 is right about the mechanism and I think understates the practical bit. The opalescent appearance in semaglutide solutions is occasionally noted and the…
-
Repeatability versus intermediate precision Replied, post #33 · Analytics › Method validation · 21 Jun 2025 · 30 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #51 · Access › Insurance & coverage · 10 Jun 2025 · 20 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #44 · Compounds › Cagrilintide & amylin analogues · 19 May 2025 · 1 like I read post #42 twice before replying, because I had assumed the opposite. Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #5 · Evidence › Journal club · 15 May 2025 · 0 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #30 · Compounds › Oral incretins · 11 May 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #111 · Compounds › Semaglutide · 10 May 2025 · 10 likes post #110 is right about the mechanism and I think understates the practical bit. The opalescent appearance in semaglutide solutions is occasionally noted and the…
-
Vagal afferents and the gut-brain pathway Replied, post #3 · Pharmacology › Receptor biology · 5 May 2025 · 0 likes post #2 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Water content on a certificate and why it changes the arithmetic Replied, post #12 · Analytics › COA interpretation · 4 May 2025 · 0 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #30 · Evidence › Journal club · 27 Apr 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #49 · Wellbeing › Mental health · 22 Apr 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Dizziness on standing: the ordinary explanation first Replied, post #2 · Nutrition & Training › Hydration & electrolytes · 21 Apr 2025 · 19 likes Worth separating two things that the opening post runs together. Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #95 · Compounds › Cagrilintide & amylin analogues · 9 Apr 2025 · 19 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #59 · Analytics › Mass spectrometry · 7 Apr 2025 · 10 likes post #58 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #131 · Access › International · 29 Mar 2025 · 9 likes post #130 answers the question as asked. The question underneath it is different. Licensed prescribing: where a compound is approved, prescribing is restricted to…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #32 · Compounds › Secretagogues & GH axis · 28 Mar 2025 · 21 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #46 · Compounds › Cagrilintide & amylin analogues · 27 Mar 2025 · 0 likes This follows post #43 rather than contradicting it. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a…
-
Maintainer handover: how it works Replied, post #73 · Meta › Wiki maintenance · 18 Mar 2025 · 5 likes Worth separating two things that post #69 runs together. Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #37 · Access › Pricing · 18 Mar 2025 · 0 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #19 · Access › Insurance & coverage · 15 Mar 2025 · 0 likes On post #15 — agreed on the reasoning, with one qualification. Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point,…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #43 · Practice › Reconstitution · 28 Feb 2025 · 7 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
When "no data" is the complete and final answer Replied, post #101 · Compounds › Other compounds · 24 Feb 2025 · 0 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Distinguishing a deletion sequence by mass alone Replied, post #111 · Analytics › Mass spectrometry · 20 Feb 2025 · 27 likes Resolution: "high resolution" commonly means
-
Ipamorelin selectivity claims and where they came from Replied, post #13 · Compounds › Secretagogues & GH axis · 14 Feb 2025 · 0 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
A supplier that answers analytical questions with restated claims Replied, post #20 · Sourcing › Red flags · 6 Feb 2025 · 17 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #21 · Data & Tools › Calculators · 29 Jan 2025 · 0 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Distinguishing a deletion sequence by mass alone Replied, post #10 · Analytics › Mass spectrometry · 22 Jan 2025 · 1 like Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Follow-up: Individual participant data versus aggregate data Replied, post #82 · Evidence › Meta-analyses · 11 Jan 2025 · 22 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Washout with a one-week half-life: the arithmetic Replied, post #43 · Research Methods › N-of-1 designs · 30 Nov 2024 · 5 likes I read post #41 twice before replying, because I had assumed the opposite. Blinding: blinding yourself (not knowing which condition you are in) removes expectation…
-
Why "any advice?" is the least effective ending for a post Replied, post #33 · Start Here › How to Ask · 13 Nov 2024 · 24 likes This follows post #30 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Identical chromatograms across two different lots Replied, post #48 · Sourcing › Red flags · 11 Nov 2024 · 7 likes post #47 answers the question as asked. The question underneath it is different. Anonymity: a supplier that will not disclose legal name, address, or responsible person…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #97 · Compounds › Other compounds · 6 Nov 2024 · 7 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
Requesting a page: what makes a good request — what changed since Started this topic · Documentation › Wiki requests · 8 Oct 2024 · 48 likes Posting this under the heading it deserves: Requesting a page: what makes a good request — what changed since Everything below is what sits behind that. Nominating…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #3 · Clinical › Comorbidities · 25 Sep 2024 · 1 like Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Second pass at: Reimbursement variation across member states Replied, post #8 · Regional › European Union · 11 Sep 2024 · 21 likes On post #4 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
-
Revisiting: A staff appointment, and what the role involves Started this topic · Meta › Announcements · 12 Aug 2024 · 1 like Revisiting: A staff appointment, and what the role involves — setting out what I have, and where I think it stops being reliable. Process question about how this site…
-
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #12 · Practice › Administration · 11 Aug 2024 · 11 likes Picking up post #9: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Guidelines revision: what changed and why Replied, post #27 · Meta › Announcements · 25 Jul 2024 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Blind submission and why it changes minds Replied, post #18 · Sourcing › Independent verification · 19 Jul 2024 · 23 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
The mass-error checker and its intended scope Replied, post #132 · Data & Tools › Calculators · 18 Jul 2024 · 0 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #71 · Practice › Dosing & titration · 8 Jul 2024 · 31 likes Worth separating two things that post #67 runs together. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well,…